1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information about The Cigna Group's share repurchase activity for the quarter ended March 31, 2024:
+Added: The following table provides information about The Cigna Group's share repurchase activity for the quarter ended June 30, 2024:
Period Total # of shares purchased (1)
5 unchanged sentences
of publicly announced program (3) (in millions)
−Removed: January 1-31, 2024 253,716 $ 303.91 253,748 $ 11,229
−Removed: February 1-29, 2024 9,832,165 (1) 9,828,122 $ 7,284
−Removed: March 1-31, 2024 336,493 $ 336.19 — $ 7,284
+Added: April 1-30, 2024 300 $ 367.11 — $ 7,284
+Added: May 1-31, 2024 2,863,087 (1) 2,860,996 $ 6,900
+Added: June 1-30, 2024 1,807,858 $ 339.33 1,806,656 $ 6,293
Total 4,671,245 (1) 4,667,652 N/A
1 unchanged sentence
1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised.
−Removed: Employees tendered (32) shares in January, 4,043 shares in February and 336,493 shares in March 2024.
−Removed: Amount purchased in February 2024 also reflects the initial delivery of 7.6 million shares pursuant to the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part 1, Item 2.
−Removed: Such repurchase was made pursuant to the Company's share repurchase program described in note (2) below.
−Removed: Average price paid per share for the period February 1-29, 2024 for shares not purchased pursuant to the accelerated share repurchase agreements ("ASR agreements") was $331.54.
+Added: Employees tendered 300 shares in April, 2,091 shares in May and 1,202 shares in June 2024.
+Added: Amount purchased in May 2024 also reflects the final settlement of approximately 1.7 million shares for no additional consideration pursuant to the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part 1, Item 2.
+Added: For shares not purchased pursuant to the accelerated share repurchase agreements, the average price paid per share for the period May 1 to May 31, 2024 was $337.95 and for the quarter ended June 30, 2024 was $338.79.
(2) Additionally, the Company maintains a share repurchase program authorized by the Board.
3 unchanged sentences
The program may be suspended or discontinued at any time and does not have an expiration date.
−Removed: In February 2024, as part of our share repurchase program, we entered into ASR agreements to repurchase $3.2 billion of common stock in aggregate.
−Removed: In February 2024, we received an initial delivery of approximately 7.6 million shares of our common stock representing $2.6 billion of the total $3.2 billion remitted.
−Removed: Remaining share repurchase authority was $7.3 billion as of May 1, 2024.
−Removed: See Note 8 to the Consolidated Financial Statements for further information on our ASR agreements.
(3) Approximate dollar value of shares is as of the last date of the applicable month and excludes the impact of excise tax.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.